Axe Compute Inc
predictive-oncology.comWhat Do They Do?
Provides on-demand computing capacity powered by graphics processing units for enterprises, artificial intelligence developers and large-scale workload operators, plus drug-discovery services and tumor models for cancer researchers.
10-K for FY2025, filed Mar 31, 2026
How Do They Make Money?
Compute customers prepay to reserve capacity, priced by the hour for each graphics processor; drug-research customers make partial payments before research and pay the balance after delivery of data or reports.
10-K for FY2025, filed Mar 31, 2026
$125.3K
-
10-K for FY2025, filed Mar 31, 2026
$125.3K ↗
Who Are Their Customers?
Compute capacity is supplied through managed service agreements; research engagements are set out in master service agreements and statements of work, typically covering research with data or reports delivered.
10-K for FY2025, filed Mar 31, 2026Through our Compute Services segment, we provide enterprises, AI developers, and large-scale workload operators with on-demand access to…View ↗
Our infrastructure is designed to serve both traditional enterprise AI workloads and participants in decentralized physical infrastructure…View ↗
The specific pattern of revenue recognition for CRO services is determined on a case-by-case basis according to the facts and circumstances…View ↗
Do Revenues Turn Into Profits?
No. It lost $233.1M in FY2025.
10-K for FY2025, filed Mar 31, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$17.2MView ↗
- ▲ +731% (Loss)
- vs −$2.1M in Q2 FY2025
-
Sep 11, 2026
Completed the sale of Helomics to DataMeds
The sale completes the transition to a GPU-as-a-Service company.
Sources
8-K, filed Sep 17, 2026
On September 11, 2026, Axe Compute Inc., a Delaware corporation (the “Company”), entered into a Stock Purchase Agreement (the “Agreement”)…View ↗
-
Aug 17, 2026
Agreed with Duos Technologies on 55 MW of AI data center capacity
The agreements involve over $500 million in expected aggregate payments; minority equity investments remain under nonbinding term sheets.
Sources
8-K, filed Aug 17, 2026
On August 17, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has entered into agreements with…View ↗
-
Jul 27, 2026
Won a five-year customer agreement for a U.S. AI infrastructure cluster
The contract has a total value of over $1.5 billion through the Axe Compute Build program.
Sources
8-K, filed Jul 27, 2026
On July 27, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has secured a new five-year customer…View ↗
-
Jul 22, 2026
Secured more than $1.3 billion in new Build program contracts
The customer contracts cover projects in the United States and Europe.
Sources
8-K, filed Jul 22, 2026
On July 22, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has secured more than $1.3 billion in…View ↗
Shrinking. Revenue fell 91% in 4 years, from $1.4M in FY2021 to $125.3K in FY2025, about 46% a year.
From oncology to computing
The older report centered the business on AI-guided cancer drug discovery, clinical testing, tumor models, protein research and medical-fluid equipment. The latest report prioritizes distributed computing capacity for AI and high-performance workloads through Aethir, while retaining drug-discovery services.
10-K for FY2022, filed Mar 21, 2023 10-K for FY2025, filed Mar 31, 2026In late 2025, we expanded our business strategy to include a compute business under the Axe Compute brand, and renamed the Company Axe…View ↗
Axe Compute also continues to operate its Drug Discovery Services business, which we also refer to as our ‘legacy’ business (“Legacy…View ↗
Through our Compute Services segment, we provide enterprises, AI developers, and large-scale workload operators with on-demand access to…View ↗
Loading...
